Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes

NCT00447382 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

330

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 1

Interventions

DRUG: insulin detemir
DRUG: insulin aspart
DRUG: insulin detemir

Sponsor

Novo Nordisk A/S